NZSTF yields 4.85% · JNJ yields 2.13%● Live data
📍 NZSTF pulled ahead of the other in Year 1
Combined, NZSTF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NZSTF + JNJ for your $10,000?
NZX Limited operates a stock exchange in New Zealand. The company operates through five segments: Capital Markets Origination, Secondary Markets, Data & Insights, Funds Management, and Wealth Technologies. The Capital Markets Origination segment provides issuer services for current and prospective customers. The Secondary Markets segment provides trading and post-trade services for securities and derivatives markets, as well as provides central securities depository; and acts as a market operator for Fonterra Co-Operative Group, the Electricity Authority, and the Ministry for the Environment. The Data & Insights segment offers information services for the securities and derivatives markets; and analytics for the dairy sector. The Funds Management segment provides superannuation and KiwiSaver, and Smartshares exchange traded funds. The Wealth Technologies segment offers funds administration and custodian services. It also offers NZX Wealth Technologies, a platform that enables advisers and brokers to manage client investments. NZX Limited was founded in 1866 and is headquartered in Wellington, New Zealand.
Full NZSTF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.